Atorvastatin as an immunomodulatory adjunct in ulcerative colitis, beyond lipid lowering to inflammation control: a randomized controlled pilot study

BackgroundUlcerative colitis (UC) is a long-term condition marked by recurrent episodes of inflammation affecting the colonic mucosa. Despite mesalamine’s or 5-amino salicylic acid’s (5-ASA) established role in inducing and maintaining remission, some patients experience persistent symptoms and infl...

Бүрэн тодорхойлолт

Номзүйн дэлгэрэнгүй

Үндсэн зохиолчид:	Mohannad O. Khrieba, Furqan M. Abdulelah, Nada A. Alsaleh, Hayam Ali AlRasheed, Tarek I. Ahmed, Azza El-Sayed Mansy, Manal A. Hamouda, Eslam Habba, Nora Elshorbagi, Ahmed G. Abd Elhameed, Eman Hamza, Muhammed M. Salahuddin, Shereen A. Mourad, Marwa Kamal
Формат:	Artigo
Хэл сонгох:	Inglês
Хэвлэсэн:	Frontiers Media S.A. 2025-10-01
Цуврал:	Frontiers in Pharmacology
Нөхцлүүд:	atorvastatin crp esr IBDQ-32 SCCAI ulcerative colitis
Онлайн хандалт:	https://www.frontiersin.org/articles/10.3389/fphar.2025.1690513/full
Шошгууд:	Шошго нэмэх Шошго байхгүй, Энэхүү баримтыг шошголох эхний хүн болох!